capsensixx AG signed a letter of intent (LOI) in connection with an intended management buyout concerning its equity interest in coraixx GmbH & Co. KGaA with Sven Ulbrich. Within the context of sharpening capsensixx AG's business focus, the current member of the Supervisory Board Gregor Langer is to be appointed to the Management Board. CEO Sven Ulbrich leaves the Management Board of capsensixx AG with immediate effect and concentrate in future fully on his activity as managing director of Oaklet GmbH.